Journal
ACTA VIROLOGICA
Volume 61, Issue 1, Pages 48-55Publisher
AEPRESS SRO
DOI: 10.4149/av_2017_01_48
Keywords
influenza; T-705 (Favipiravir); TNF-alpha; cytokines; viral load
Categories
Funding
- Toyama Chemical Co. Ltd.
Ask authors/readers for more resources
Influenza virus infection induces the production of various cytokines, which play important roles in the pathogenesis of infection. Among the cytokines induced by influenza, tumor necrosis factor a (TNF-alpha) production has been correlated with the severity of lung lesions. We investigated the effects of T-705 (Favipiravir, 6-fluoro-3-hydroxy-2-pyrazinecarboxamide) on cytokine production due to influenza virus infection in vitro and in vivo, compared with oseltamivir or GS 4071, an active form of oseltamivir. TNF-alpha production in mouse macrophage-derived P388D1 cells infected with the influenza virus was lower following treatment with T-705 at concentrations of 0.3 to 100 mu g/ml than treatment with GS 4071 at the same concentrations. The effect of treatment with T-705 on the cytokine production induced by the influenza virus infection was investigated in mouse influenza virus infection model. At 48 h post-infection (p.i.) T-705 significantly suppressed the viral load in the lungs and TNF-alpha production in the airways of infected mice even when viral loads were high. Furthermore, T-705 suppressed only TNF-alpha production from the early phase of infection. In this study, T-705 showed the antiviral activity of reducing pulmonary viral load compared with oseltamivir, thereby suppressing the TNF-alpha production. This feature of T-705 is benefit against severe influenza infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available